Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Hepatology International

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12072-008-9106-xPMID 19669378PMCID PMC2712314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver histology as predictor of outcome in patients with acute-on-chronic liver failure (ACLF)

  2011cited by this paper
• Bacterial, Parasitic, and Fungal Infections of the Liver, Including Liver Abscess

  2010cited by this paper
• Hemodynamic Studies in Acute-on-Chronic Liver Failure

  2009cited by this paper
• Hepatitis B: reflections on the current approach to antiviral therapy.

  2008cited by this paper
• A revisit of prophylactic lamivudine for chemotherapy‐associated hepatitis B reactivation in non‐Hodgkin's lymphoma: A randomized trial

  2008cited by this paper
• Immunological response to hepatitis B vaccination in patients with AIDS and virological response to highly active antiretroviral therapy

  2008cited by this paper
• Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus‐related chronic liver disease

  2008cited by this paper
• Rituximab-induced hepatitis C virus reactivation after spontaneous remission in diffuse large B-cell lymphoma.

  2008cited by this paper
• Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure

  2007cited by this paper
• Characteristics of acute and sub‐acute liver failure in China: nomination, classification and interval

  2007cited by this paper
• Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.

  2007cited by this paper
• Lamivudine for treatment of spontaneous exacerbation and reactivation after immunosuppressive therapy in patients with hepatitis B virus infection.

  2007cited by this paper
• Pre-transplant optimization by Molecular Adsorbent Recirculating System in patients with severely decompensated chronic liver disease.

  2007cited by this paper
• Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.

  2007cited by this paper
• Model for end‐stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure

  2007cited by this paper
• MARS®: a futile tool in centres without active liver transplant support

  2007cited by this paper
• Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.

  2007cited by this paper
• Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome

  2007cited by this paper
• Outcomes of patients with hepatitis B who developed antiviral resistance while on the liver transplant waiting list.

  2007cited by this paper
• Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death.

  2007cited by this paper
• Actin‐free Gc globulin: A rapidly assessed biomarker of organ dysfunction in acute liver failure and cirrhosis

  2007influential reference
• Acute liver failure: Summary of a workshop

  2007influential reference
• ADMA correlates with portal pressure in patients with compensated cirrhosis

  2007cited by this paper
• Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis

  2007cited by this paper
• Utility of admission cardiac troponin and “Ischemia Modified Albumin” measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department

  2006cited by this paper
• Late lethal hepatitis B virus reactivation after rituximab treatment of low‐grade cutaneous B‐cell lymphoma

  2006cited by this paper
• Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure

  2006cited by this paper
• Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure

  2006cited by this paper
• Subfulminant hepatitis B after infliximab in Crohn's disease: need for HBV-screening?

  2006cited by this paper
• Accumulation of Symmetric Dimethylarginine in Hepatorenal Syndrome

  2006cited by this paper
• Risk factors, Sequential Organ Failure Assessment and Model for End‐stage Liver Disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit

  2006cited by this paper
• Long-term results of liver transplant in patients with chronic viral hepatitis-related liver disease in Singapore.

  2006cited by this paper
• Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab.

  2006cited by this paper
• Ischemia-modified albumin predicts mortality in ESRD.

  2006cited by this paper
• Removal of Metabolites, Cytokines and Hepatic Growth Factors by Extracorporeal Liver Support in Children

  2005cited by this paper
• Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B.

  2005cited by this paper
• AASLD position paper: The management of acute liver failure

  2005cited by this paper
• Patients with acute on chronic liver failure display "sepsis-like" immune paralysis.

  2005cited by this paper
• Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation – a pilot study

  2005cited by this paper
• Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon α-2b therapy

  2005cited by this paper
• Outcome from molecular adsorbent recycling system (MARS™) liver dialysis following drug‐induced liver failure

  2005cited by this paper
• Effects of artificial liver support system on patients with acute or chronic liver failure.

  2005cited by this paper
• Pathophysiological effects of albumin dialysis in acute‐on‐chronic liver failure: A randomized controlled study

  2004cited by this paper
• Effect of artificial liver support system on patients with severe viral hepatitis: a study of four hundred cases.

  2004cited by this paper
• Superimposed acute hepatitis E infection in patients with chronic liver disease.

  2004cited by this paper
• CYTOCHINES AND LIVER FAILURE: MODIFICATION OF TNF-a AND IL-6 IN PATIENTS WITH ACUTE ON CHRONIC LIVER DECOMPENSATION TRETED WITH MOLECULAR ADSORBENT RECYCLING SYSTEM (MARS)

  2004cited by this paper
• Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease

  2004cited by this paper
• Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis.

  2004cited by this paper
• Molecular adsorbent recirculating system for acute and acute‐on‐chronic liver failure: A meta‐analysis

  2004cited by this paper
• Application of Molecular Adsorbents Recirculating System to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome

  2003cited by this paper
• Live-donor liver transplantation for acute-on-chronic hepatitis B liver failure

  2003cited by this paper
• Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation

  2003cited by this paper
• Economic evaluation and 1‐year survival analysis of MARS in patients with alcoholic liver disease

  2003cited by this paper
• Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure

  2003cited by this paper
• The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis.

  2003cited by this paper
• Risk Factors for Nonhepatic Surgery in Patients with Cirrhosis

  2003cited by this paper
• Acute-on-Chronic Liver Failure: Pathophysiological Basis of Therapeutic Options

  2002influential reference
• Hepatitis E virus superinfection in patients with chronic liver disease

  2002cited by this paper
• Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study

  2002cited by this paper
• The pathophysiological basis of acute-on-chronic liver failure.

  2002influential reference
• Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non‐Hodgkin's lymphoma

  2002cited by this paper
• Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients.

  2002cited by this paper
• Favorable outcome of orthotopic liver transplantation in a patient with subacute liver failure due to the emergence of a hepatitis B YMDD escape mutant virus.

  2001cited by this paper
• Short‐term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems

  2001cited by this paper
• Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial

  2000cited by this paper
• The systemic inflammatory response syndrome in acute liver failure

  2000cited by this paper
• Complications of cirrhosis. I. Portal hypertension.

  2000cited by this paper
• Cytokines in alcoholic and nonalcoholic steatohepatitis.

  2000cited by this paper
• Successful orthotopic liver transplantation for lamivudine-associated YMDD mutant hepatitis B virus.

  2000cited by this paper
• Short‐term prognosis in critically ill patients with liver cirrhosis: an evaluation of a new scoring system

  2000cited by this paper
• Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems.

  1998cited by this paper
• Morbid prognostic features in patients with chronic liver failure undergoing nonhepatic surgery.

  1997cited by this paper
• Outcome prediction for patients with cirrhosis of the liver in a medical ICU: A comparison of the APACHE scores and liver-specific scoringsystems

  1996cited by this paper
• Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

  1996cited by this paper
• [Acute-on-chronic liver failure].

  1995cited by this paper
• Liver transplantation for severe acute liver failure after herbal medicine (Teucrium polium) administration.

  1995cited by this paper
• Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.

  1993cited by this paper
• Acute liver failure: redefining the syndromes.

  1993cited by this paper
• Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites.

  1993cited by this paper
• Fungal infection: a common, unrecognised complication of acute liver failure.

  1991cited by this paper
• Prospective study of bacterial infection in acute liver failure: An analysis of fifty patients

  1990cited by this paper
• Fulminant and Subfulminant Liver Failure: Definitions and Causes

  1986cited by this paper
• Late onset hepatic failure: Clinical, serological and histological features

  1986cited by this paper

• Dynamic inflammation-based prognostication in acute-on-chronic liver failure: The COSSH-CAR model as a step forward in personalized risk stratification

  2026cites this paper
• Prognostic Value of Neutrophil-to-lymphocyte Ratio in Patients with Acute-on-chronic Liver Failure in Comparison with Standard Scores: A Cross-sectional Observational Study from a Tertiary Care Hospital in South India.

  2026cites this paper
• Comparative Efficacy of Standard‐Volume Plasma Exchange Versus High‐Volume Plasma Exchange in Patients With Acute‐on‐Chronic Liver Failure

  2026cites this paper
• Epidemiological Characteristics of Acute‐on‐Chronic Liver Failure in Patients With Compensated Liver Disease: A Systematic Review and Meta‐Analysis

  2025cites this paper
• Forecasting Medium Term Mortality in Alcohol-related Acute on Chronic Liver Failure (ACLF): A Study from A Tertiary Care Center.

  2025cites this paper
• Diabetes mellitus is linked to higher mortality in alcohol-related acute-on-chronic liver failure

  2025cites this paper
• Indian National Association for the Study of Liver (INASL) Guidance Statements for Determining Futility in Liver Transplantation.

  2025cites this paper
• Role of procalcitonin in identifying systemic inflammatory response syndrome and sepsis in acute-on-chronic liver failure and its impact on survival

  2025cites this paper
• Identification of key biomarkers associated with necroptosis and immune infiltration in hepatitis B virus-related acute-on-chronic liver failure

  2025cites this paper
• Commercialization of Elastography in India: A Critical Analysis of Screening Practices and Healthcare Policy Implications

  2025cites this paper
• Incidence and Short‐Term Prognosis of Acute‐On‐Chronic Liver Failure Defined by Japanese Criteria: A Single‐Center Retrospective Cohort Study From Urban Japan

  2025cites this paper
• Acute versus acute-on-chronic liver failure: comparative analysis of clinical outcomes in Beijing, China

  2025cites this paper
• Acute-on-Chronic Liver Failure—Current Management and Future Perspectives

  2025cites this paper
• The Impact of Functional Status on Post-Liver Transplant Outcomes in Acute-On-Chronic Liver Failure

  2025cites this paper
• Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia

  2025cites this paper
• AKI in ACLF: navigating the complex therapeutic puzzle

  2025cites this paper
• Liver Failure, Hepatic Encephalopathy, and Infection Contribute to Mortality Risk in a Global Cirrhosis Cohort.

  2025cites this paper
• Acute-on-chronic liver failure—Prime time for unity

  2025cites this paper
• Circulating Cell‐Free Mitochondrial DNA as a Prognostic Biomarker in Patients With HBV‐Related Acute‐on‐Chronic Liver Failure

  2025cites this paper
• Single-cell multimodal analysis reveals the dynamic immunopathogenesis of HBV-ACLF progression

  2025cites this paper
• Acute-on-Chronic Liver Failure: Steps Towards Consensus

  2025cites this paper
• Adult-to-adult right lobe graft living donor liver transplantation for acute-on-chronic liver failure: a single-centre retrospective study in Vietnam

  2024cites this paper
• Acute-on-chronic liver failure-steps for harmonization of the definition!

  2024cites this paper
• Management of pediatric liver failure with therapeutic plasma exchange and continuous renal replacement therapy: A retrospective observational study

  2024cites this paper
• The 90‐Day Survival Threshold: A Pivotal Determinant of Long‐Term Prognosis in HBV‐ACLF Patients – Insights from a Prospective Longitudinal Cohort Study

  2024cites this paper
• Editorial: Decoding ACLF—Sub‐Phenotyping to Advance Precision Medicine in Acute‐On‐Chronic Liver Failure

  2024cites this paper
• Lebererkrankungen auf der Intensivstation

  2024cites this paper
• Short-Term Efficacy of Tenofovir Alafenamide in Acute-On-Chronic Liver Failure: A Single Center Experience

  2024cites this paper
• Acute on Chronic Liver Failure: Lessons from a Decade of EASL-CLIF Definition and Scoring Systems

  2024cites this paper
• Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement

  2024cites this paper
• Clinical Profile and Outcome of Patients Presenting With Acute-on-Chronic Liver Failure: A Single-Center Experience

  2024cites this paper
• Impact of Diabetes, Drug-Induced Liver Injury, and Sepsis on Outcomes in Metabolic Dysfunction Associated Fatty Liver Disease–Related Acute-on-Chronic Liver Failure

  2024influential citation
• Prior metabolic and bariatric surgery is an independent determinant of severity of decompensation in alcohol‐associated liver disease

  2024cites this paper
• Risk factors and prognostic impact of new decompensated events in hospitalized patients with decompensated cirrhosis

  2024cites this paper
• Acute-on-chronic liver failure: a retrospective review of cases at a transplantation center in Brazil

  2024cites this paper
• Therapeutic Plasma Exchange in Children With Acute and Acuteon-Chronic Liver Failure: A Single-Center Experience.

  2024cites this paper
• Development of novel prognostic models based on dynamic changes in risk factors for hepatitis B associated acute-on-chronic liver failure:a 10-year retrospective study

  2024cites this paper
• Quality Evaluation of Guidelines for the Diagnosis and Treatment of Liver Failure

  2024cites this paper
• Renal resistive index measurements by ultrasound in patients with liver cirrhosis: Magnitude and associations with renal dysfunction

  2024cites this paper
• Liver transplantation consideration and evaluation: a life-saving treatment in acute-on-chronic liver failure

  2024cites this paper
• Racial and ethnic disparities in post‐liver transplant outcomes for patients with acute‐on‐chronic liver failure: An analysis of the UNOS database

  2024cites this paper
• Nutritional counseling's impact on muscle mass and quality of life in stage 4 chronic kidney disease malnourished patients

  2024cites this paper
• Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosis

  2024cites this paper
• Early plasma exchange and continuous renal replacement therapy improve puerperal prognosis in hepatitis B virus-related acute-on-chronic liver failure in pregnancy

  2024cites this paper
• Prognosis algorithms for acute decompensation of cirrhosis and ACLF

  2024cites this paper
• APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure

  2024cites this paper
• Severe hepatitis E virus genotype 3b in a patient with alcohol‑associated liver disease: A case report

  2024cites this paper
• Review article: Emerging and current management of acute‐on‐chronic liver failure

  2023cites this paper
• Intensive care management of acute-on-chronic liver failure

  2023cites this paper
• Alcohol Responsive Genes in the Neutrophils of Acute-On-Chronic Liver Failure Reveal Modulation of Intracellular Calcium, ROS, and Phagocytosis

  2023cites this paper
• Transcriptomics unveils immune metabolic disruption and a novel biomarker of mortality in patients with HBV-related acute-on-chronic liver failure

  2023cites this paper
• Consensus document on acute-on-chronic liver failure (ACLF) established by the Mexican Association of Hepatology.

  2023cites this paper
• Challenges in Diagnosis and Therapeutic Approach of Acute on Chronic Liver Failure—A Review of Current Evidence

  2023cites this paper
• Hepatitis B virus infection in patients with Wilson disease: A large retrospective study

  2023cites this paper
• Determinants of Short-term Mortality in Liver Cirrhosis with Acute Kidney Injury: A Prospective Observational Study

  2023cites this paper
• Acute-on-chronic liver failure: far to go—a review

  2023cites this paper
• Definition, diagnosis and epidemiology of acute‐on‐chronic liver failure

  2023cites this paper
• A 15-Year Retrospective Study of Supportive Extracorporeal Therapies Including Plasma Exchange and Continuous Venovenous Hemodiafiltration of 114 Adults with Acute Liver Failure Awaiting Liver Transplantation

  2023cites this paper
• Omics in acute‐on‐chronic liver failure

  2023cites this paper
• Infections in Patients with Severe Alcoholic Hepatitis: A Retrospective Study

  2023cites this paper
• EASL Clinical Practice Guidelines on acute-on-chronic liver failure.

  2023cites this paper
• Acute-On-Chronic Liver Failure: Current Interventional Treatment Options and Future Challenges

  2023cites this paper
• Novel treatment of acute and acute‐on‐chronic liver failure: Interleukin‐22

  2023cites this paper
• SOCS1 methylation level is associated with prognosis in patients with acute-on-chronic hepatitis B liver failure

  2023cites this paper
• Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium.

  2023cites this paper
• Epidemiology, characteristics, and outcomes of patients with acute‐on‐chronic liver failure in Australia

  2023cites this paper
• Risk factors of nosocomial infection in patients underwent artificial liver support system: a retrospective case–control study

  2023cites this paper
• Serum cytokine and chemokine profiles and disease prognosis in hepatitis B virus-related acute-on-chronic liver failure

  2023cites this paper
• Acute kidney injury in patients with acute-on-chronic liver failure: clinical significance and management

  2023cites this paper
• Plasma S100A8 and S100A9 Are Strong Prognostic Factors for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure

  2023cites this paper
• Frequency, Clinical Presentation, and Outcome of Acute-on-chronic Liver Failure among Decompensated Cirrhosis of Liver Patients in a Tertiary Care Hospital

  2023cites this paper
• Predicting Post-Liver Transplant Outcomes in Patients with Acute-on-Chronic Liver Failure using Expert-Augmented Machine Learning

  2023cites this paper
• Determination of HMGB1 in hepatitis B virus-related acute-on-chronic liver failure patients with acute kidney injury: Early prediction and prognostic implications

  2023cites this paper
• Risk factors and molecular epidemiology of fecal carriage of carbapenem resistant Enterobacteriaceae in patients with liver disease

  2023cites this paper
• Superoxide dismutase 2 as a predictor in patients with hepatitis B virus-associated acute-on-chronic liver failure

  2023cites this paper
• Acute-on-chronic liver failure due to hepatitis B

  2023cites this paper
• Acute-on-chronic liver failure: Controversies and consensus

  2023cites this paper
• Development of a novel prognostic assessment model for hepatitis B virus-related acute-on-chronic liver failure based on reexamination results

  2023cites this paper
• Novel Therapeutic Approaches in Treatment of Acute-on-Chronic Liver Failure

  2023cites this paper
• Granulocyte-colony stimulating factor in acute-on-chronic liver failure: Systematic review and meta-analysis of randomized controlled trials

  2023cites this paper
• Efficacy of Granulocyte Colony-Stimulating Factor in Acute on Chronic Liver Failure: A Systematic Review and Survival Meta-Analysis

  2023cites this paper
• Controversies in Liver Transplantation

  2023cites this paper
• The efficacy and safety of granulocyte colony-stimulating factor in the treatment of acute-on-chronic liver failure: A systematic review and meta-analysis

  2023cites this paper
• Acute Decompensated Liver: When to Transplant?

  2023cites this paper
• Drug induced liver injury: causative agents and predictors for the outcome - a retrospective study at Tanta University Hospital, Egypt.

  2023cites this paper
• Risk factors for the mortality of hepatitis B virus-associated acute-on-chronic liver failure: a systematic review and meta-analysis

  2023cites this paper
• A nomogram based on psoas muscle index predicting long-term cirrhosis incidence in non-cirrhotic patients with HBV-related acute‑on‑chronic liver failure

  2023cites this paper
• Adequate Chelation and Cupriuresis in Hepatic Wilson Disease Patients Under Combination (Chelator + Zinc) Therapy at 2 Years of Follow-up.

  2023cites this paper
• Knockdown of CXCL1 improves ACLF by reducing neutrophil recruitment to attenuate ROS production and hepatocyte apoptosis

  2023cites this paper
• Granulocytic myeloid-derived suppressor cells increase infection risk via the IDO/IL-10 pathway in patients with hepatitis B virus-related liver failure

  2023cites this paper
• Patients hospitalized with alcohol‐related liver disease and prior bariatric surgery are more prone to develop acute‐on‐chronic liver failure

  2023cites this paper
• Hemostasis in cirrhosis: understanding destabilising factors during acute decompensation.

  2023cites this paper
• Midodrine versus Albumin to Prevent Paracentesis Induced Circulatory Dysfunction in Acute on Chronic Liver Failure Patients in the Outpatient Clinic-a Randomized Controlled Trial.

  2023cites this paper
• Acute-on-chronic liver failure: clinical course and liver transplantation

  2023cites this paper
• Bikunin: A Promising Prognostic Biomarker for Acute-on-Chronic Liver Failure in Patients with Viral Hepatitis B

  2023cites this paper
• The Role of the Transjugular Intrahepatic Porto-Systemic Shunt in an Emergency Setting

  2023cites this paper
• Acute on chronic liver failure: prognostic models and artificial intelligence applications

  2023cites this paper
• Viral Hepatitis and Acute-on-Chronic Liver Failure.

  2023cites this paper
• Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure

  2023cites this paper
• Role of Acute Hepatitis E Virus Super Infection in Progression Stage of Liver Cirrhosis

  2023cites this paper